53 Biggest Movers From Yesterday
Gainers
DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.
Cyren Announces $10.2M Private Placement Priced At Premium To Market
Cyren (NASDAQ:CYRN), today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise approximately $10.2 million through the
38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
26 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday.
46 Biggest Movers From Yesterday
Gainers
Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.
Why CYREN’s Stock Is Trading Higher Today
CYREN's (NASDAQ:CYRN) shares are trading higher on abnormally-high volume. The company announced it teamed with TD SYNNEX to distribute next gen anti-phishing solution in North America. The stock is also seeing retail investor interest.
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results.
20 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in cash.
CYREN Q2 EPS $(0.06), Inline, Sales $7.60M Miss $7.80M Estimate
CYREN (NASDAQ:CYRN) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $7.60 million which